Emmanuella Guenova

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


222 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ...
In press
 
Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.
Blanchard G., Atallah I., Blanchard M., Fehrenbacher B., Schaller M., Riccio O., Ballerini C., Candotti F., Guenova E. The British journal of dermatology. Peer-reviewed.
[DOI][Pmid][serval:BIB_FCE7997FD1E1]
 
Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members.
Elsayad K., Guenova E., Fournier B., Fernandes C., Clementel E., Papadavid E., Barry M.B., Pavlotsky F., Assaf C., Ortiz-Romero P.L. et al. International journal of radiation oncology, biology, physics. Peer-reviewed.
[DOI][Pmid][serval:BIB_14967806240F]
 
Darier disease: Current insights and challenges in pathogenesis and management.
Ettinger M., Kimeswenger S., Deli I., Traxler J., Altrichter S., Noack P., Wikstrom J.D., Guenova E., Hoetzenecker W. Journal of the European Academy of Dermatology and Venereology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F63464DDC09]
 
Single-centre experience with tralokinumab in dupilumab-experienced and naïve patients with atopic dermatitis.
Fossati C., Guenova E., Conrad C., Gilliet M., Seremet T. Journal of the European Academy of Dermatology and Venereology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EFC6FDA7CFE4]
 
Haematogenous seeding in mycosis fungoides and Sézary syndrome: Current evidence and clinical implications.
Gniadecki R., Guenova E., Querfeld C., Nicolay J.P., Scarisbrick J., Sokol L. The British journal of dermatology. Peer-reviewed.
[DOI][Pmid][serval:BIB_D9AD55C8E0FE]
 
Neonatal Linear Immunoglobulin A Bullous Dermatosis: A Critical Case Recovering after Prompt Recognition, Intensive Management, and Breastfeeding Interruption - A Case Report.
Papasavva D., Dosso L., Morren M.A., Fontao L., Bruschi L., Gorostidi F., Ferry T., Guenova E., Fischer Fumeaux C.J., Joye S. Neonatology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_701D6B438C54]
2024
 
Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases.
Seremet T., Di Domizio J., Girardin A., Yatim A., Jenelten R., Messina F., Saidoune F., Schlapbach C., Bogiatzi S., Minisini F. et al., 2024/12/18. Nature communications, 15 (1) p. 10688. Peer-reviewed.
[DOI][Pmid][serval:BIB_EE04B0E74C9B]
Keratinocytes Present Staphylococcus aureus Enterotoxins and Promote Malignant and Nonmalignant T Cell Proliferation in Cutaneous T-Cell Lymphoma.
Zeng Z., Vadivel C.K., Gluud M., Namini MRJ, Yan L., Ahmad S., Hansen M.B., Coquet J., Mustelin T., Koralov S.B. et al., 2024/12. The Journal of investigative dermatology, 144 (12) pp. 2789-2804.e10. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_96839F5A8257]
 
Maintenance therapy for CTCL: importance for prevention of disease progression.
Gordon E.R., Trager M.H., Kwinta B.D., Stonesifer C.J., Lee K.J., Adeuyan O., Lapolla B.A., Akilov O.E., Enz P.A., Guenova E. et al., 2024/12. Leukemia & lymphoma, 65 (12) pp. 1883-1890. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D7743F1FF0D8]
 
Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management.
Blanchard G., Blanchard M., Bernard P., Doms J., Cortés B., Boulinguez S., Guenova E., 2024/12. JAAD case reports, 54 pp. 23-26. Peer-reviewed.
[DOI][Pmid][serval:BIB_0D7697893185]
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.
Elsayad K., Guenova E., Assaf C., Nicolay J.P., Trautinger F., Stadler R., Waldstein C., Boterberg T., Meijnders P., Kirova Y. et al., 2024/11. European journal of cancer, 212 p. 115064. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_59C5B7DF582A]
Evaluation of Sézary cell marker expression and cell death behaviour upon in vitro treatment by flow cytometry in Sézary syndrome patients.
Melchers S., Roemer M., Albrecht J.D., Assaf C., von Gugelberg C., Guenova E., Klemke C.D., Moritz RKC, Schlaak M., Stadler R. et al., 2024/09. Experimental dermatology, 33 (9) pp. e15171. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0D74764CCDB9]
Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type: A case series and review of the literature.
Winkler M., Albrecht J.D., Sauer C., Kordaß T., Guenova E., Livingstone E., Wobser M., Mitteldorf C., Géraud C., Nicolay J.P., 2024/09. The Journal of dermatology, 51 (9) pp. 1233-1239. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_565A788D2615]
 
Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
Mitsunaga K., Bagot M., Ram-Wolff C., Guenova E., von Gugelberg C., Hodak E., Amitay-Laish I., Papadavid E., Jonak C., Porkert S. et al., 2024/08/14. The British journal of dermatology, 191 (3) pp. 419-427. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7FA3BAF6F879]
 
Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group.
Kempf W., Mitteldorf C., Cerroni L., Willemze R., Berti E., Guenova E., Scarisbrick J.J., Battistella M., 2024/08. Journal of the European Academy of Dermatology and Venereology, 38 (8) pp. 1491-1503. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B83175B8CF59]
 
Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo.
Mamaghani S., Penna R.R., Frei J., Wyss C., Mellett M., Look T., Weiss T., Guenova E., Kündig T.M., Lauchli S. et al., 2024/07/24. Cells, 13 (15). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_42516D524C9F]
Paediatric-onset lymphomatoid papulosis: results of a multicentre retrospective cohort study on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
Blanchard M., Morren M.A., Busschots A.M., Hauben E., Alberti-Violetti S., Berti E., Avallone G., Tavoletti G., Panzone M., Quaglino P. et al., 2024/07/16. The British journal of dermatology, 191 (2) pp. 233-242. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4B285B4FA583]
 
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study.
Bozonnat A., Beylot-Barry M., Dereure O., D'Incan M., Quereux G., Guenova E., Perier-Muzet M., Dalle S., Grange F., Viguier M.A. et al., 2024/07. EClinicalMedicine, 73 p. 102679. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AC5F8280DCB7]
 
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
Tzoumpa S., Ingen-Housz-Oro S., de Masson A., Pham-Ledard A., El Aarbaoui T., Dereure O., Quereux G., Faiz S., de Vicq de Cumptich M., Ram-Wolff C. et al., 2024/06/20. The British journal of dermatology, 191 (1) pp. 143-144. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14C6A3C59476]
Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis.
Blanchard G., Bisig B., de Leval L., Hohl D., Guenova E., 2024/06. JAAD case reports, 48 pp. 98-102. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1EE4642C1F75]
Decoding the impact of primary cutaneous B-cell lymphomas on patients' well-being.
Bernard P., Guenova E., 2024/05. Journal of the European Academy of Dermatology and Venereology, 38 (5) pp. 794-795. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_50F6DF06816C]
 
Mosaic RASopathies concept: different skin lesions, same systemic manifestations?
Morren M.A., Fodstad H., Brems H., Bedoni N., Guenova E., Jacot-Guillarmod M., Busiah K., Giuliano F., Gilliet M., Atallah I., 2024/04/19. Journal of medical genetics, 61 (5) pp. 411-419. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_40C612FFCAF2]
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
Vadivel C.K., Willerslev-Olsen A., Namini MRJ, Zeng Z., Yan L., Danielsen M., Gluud M., Pallesen EMH, Wojewoda K., Osmancevic A. et al., 2024/04/11. Blood, 143 (15) pp. 1496-1512. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3DF042FBAE8E]
 
Aspects physiopathologiques cliniques et thérapeutiques de la maladie de Darier [Clinical, therapeutic and pathophysiological aspects of Darier's disease]
Bernard P., Blanchard M., Morren M.A., Guenova E., 2024/03/27. Revue medicale suisse, 20 (867) pp. 659-663. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B50E9268AF6F]
 
Dermatoses bulleuses auto-immunes chez les enfants [Autoimmune bullous diseases in children]
Bruschi L., Minisini F., Nidegger A., Dubois J., Iselin C., Chang Y.T., Guenova E., Morren M.A., 2024/03/27. Revue medicale suisse, 20 (867) pp. 638-647. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_69DDB0F35EC5]
 
Ein Fall von papulöser akantholytischer Dyskeratose mit IL-23/TNF-α-dominantem Immunprofil [A case of papular acantholytic dyskeratosis with IL-23/TNF-α dominant immune profile].
Ettinger M., Burner T., Lackner A., Guenova E., Kimeswenger S., Hoetzenecker W., 2024/02. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 22 (2) pp. 274-277. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EC2B0620E45E]
SARS-CoV-2-Induced Vasculitic Skin Lesions Are Associated with Massive Spike Protein Depositions in Autophagosomes.
Gawaz A., Schindler M., Hagelauer E., Blanchard G., Riel S., Vollert A., Gilliet M., Unterluggauer L., Stary G., Pospischil I. et al., 2024/02. The Journal of investigative dermatology, 144 (2) pp. 369-377.e4. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D55972044341]
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides.
Chang Y.T., Prompsy P., Kimeswenger S., Tsai Y.C., Ignatova D., Pavlova O., Iselin C., French L.E., Levesque M.P., Kuonen F. et al., 2024/01/25. Nature communications, 15 (1) p. 752. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_95FE005765C9]
 
Cryoglobulinemic vasculitis triggered by Staphylococcus aureus endocarditis with chronic hepatitis C virus co-infection: a case report and literature review.
Reinberg C., Vingerhoets S., Pavlova O., Guenova E., Papadimitriou-Olivgeris M., Comte D., 2024. Frontiers in immunology, 15 p. 1385086. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0B6B4366346E]
Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences.
Geskin L.J., Angello J.T., Bagot M., Guenova E., Nikbakht N., Querfeld C., Scarisbrick J.J., 2024/01. Clinical lymphoma, myeloma & leukemia, 24 (1) pp. 40-47. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4A1304F559F1]
Fast, bedside diagnosis of toxic epidermal necrolysis using ex vivo confocal laser scanning microscopy: A retrospective study.
Tonellotto L., Seremet T., Vernez M., Guenova E., Kuonen F., 2024/01. Journal of the European Academy of Dermatology and Venereology, 38 (1) pp. 182-185. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09F30CE70C46]
 
Old Sins Cast Long Shadows: News on Staphylococcus aureus in Cutaneous T Cell Lymphoma.
Guenova E., Ødum N., 2024/01. The Journal of investigative dermatology, 144 (1) pp. 8-10. Peer-reviewed.
[DOI][Pmid][serval:BIB_5F7862B8559A]
2023
Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma.
Ninosu N., Melchers S., Kappenstein M., Booken N., Hansen I., Blanchard M., Guenova E., Assaf C., Goerdt S., Nicolay J.P., 2023/12/27. Cancers, 16 (1) p. 141. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_636A9FF705F3]
 
Antifungal Resistance on the Rise.
Monod M., Blanchard G., Guenova E., 2023/12. The Journal of investigative dermatology, 143 (12) pp. 2332-2334. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B96EB72EBC63]
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
Latzka J., Assaf C., Bagot M., Cozzio A., Dummer R., Guenova E., Gniadecki R., Hodak E., Jonak C., Klemke C.D. et al., 2023/12. European journal of cancer, 195 p. 113343. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC0D46B51475]
Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets.
Ettinger M., Burner T., Sharma A., Chang Y.T., Lackner A., Prompsy P., Deli I.M., Traxler J., Wahl G., Altrichter S. et al., 2023/11/17. Nature communications, 14 (1) p. 7470. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D062CF696E69]
Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae.
Yamada T., Maeda M., Nagai H., Salamin K., Chang Y-T, Guenova E., Feuermann M., Monod M., 2023/11/15. Antimicrobial agents and chemotherapy, 67 (11) pp. e0093323. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E2FBBBDB640E]
Histology-based classifier to distinguish early mycosis fungoides from atopic dermatitis.
Roenneberg S., Braun S.A., Garzorz-Stark N., Stark S.P., Muresan A.M., Schmidle P., Biedermann T., Guenova E., Eyerich K., 2023/11. Journal of the European Academy of Dermatology and Venereology, 37 (11) pp. 2284-2292. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BFFB3400E2F1]
Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
Tsai Y.C., Schlaepfer T., Ignatova D., Chang Y.T., Valaperti A., Amarov B., Blanchard G., Pehr K., Vonow-Eisenring M., Urosevic-Maiwald M. et al., 2023/10/25. The British journal of dermatology, 189 (5) pp. 603-611. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_ACBD06166FA1]
Reliable and rapid identification of terbinafine resistance in dermatophytic nail and skin infections.
Blanchard G., Amarov B., Fratti M., Salamin K., Bontems O., Chang Y.T., Sabou A.M., Künzle N., Monod M., Guenova E., 2023/10. Journal of the European Academy of Dermatology and Venereology, 37 (10) pp. 2080-2089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_67E2E4B27959]
 
Vorinostat for treatment-refractory bullous pemphigoid.
Blanchard G., Solly F., Basset V., Fontao L., Blanchard M., Guenova E., 2023/10. Journal of the European Academy of Dermatology and Venereology, 37 (10) pp. e1218-e1220. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C8F343C0DE9]
 
Ex vivo harmonic generation microscopy assessment in cutaneous T-cell lymphomas diagnosis
Pavlova Olesya, Ghosh Shayantani, Blanchard Gabriela, Chang Yun-Tsan, Kim Doyoung, Staedler Davide, Bonacina Luigi, Guenova Emmanuella, 2023/09., ORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113008 dans European Journal of Cancer.
[DOI][WoS][serval:BIB_032885F6D81B]
 
HLA I shields tumor lymphocytes from NK cell-mediated elimination in the skin
Chang Yun-Tsan, Kimeswenger Susanne, Tsai Yi-Chien, Prompsy Pacome, Pavlova Olesya, Pascolo Steve, Hoetzenecker Wolfram, Guenova Emmanuella, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 112992 dans European Journal of Cancer.
[DOI][WoS][serval:BIB_184D784D3AA1]
Mechanism of action of chlormethine gel in mycosis fungoides.
Guenova E., Ortiz-Romero P.L., Poligone B., Querfeld C., 2023/09. Journal of the European Academy of Dermatology and Venereology, 37 (9) pp. 1739-1748. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A3E2E9672062]
 
Mogamulizumab-induced colitis
Blanchard Maël, Blanchard Gabriela, Guenova Emmanuella, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113089 dans European Journal of Cancer.
[DOI][WoS][serval:BIB_321F0302C1C1]
 
Multi-omics cytokine screening reveals immunosuppressive microenvironment in cutaneous T-cell lymphoma
Tsai Yi-Chien, Chang Yun-Tsan, Blanchard Gabriela, Blanchard Maël, Prompsy Pacôme, Iselin Christoph, Hötzenecker Wolfram, Pascolo Steve, Guenova Emmanuella, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113045 dans European Journal of Cancer.
[DOI][WoS][serval:BIB_5817247F4277]
 
T cell receptor beta constant 1 as a potential marker to better assess T cell clonality in skin samples
Iselin Christoph, Prompsy Pacome, André Florine, Tsai Yi-Chien, Guenova Emmanuella, Chang Yun-Tsan, 2023/09., EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 21-23 September 2023 p. 113047 dans European Journal of Cancer.
[DOI][WoS][serval:BIB_977B2EE0CC15]
 
CD38 Targeting Holds Potential for the Treatment of Aggressive Refractory Cutaneous T-Cell Lymphomas.
Pavlova O., Tsai Y.C., Chang Y.T., Vonow Eisenring M., Guenova E., 2023/07. The Journal of investigative dermatology, 143 (7) pp. 1122-1126. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_589F94F08AFD]
 
What is new about primary cutaneous B cell lymphomas.
Blanchard M., Hoetzenecker W., Blanchard G., Guenova E., 2023/06. Italian journal of dermatology and venereology, 158 (3) pp. 205-216. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D51D610CA068]
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.
Hodak E., Geskin L., Guenova E., Ortiz-Romero P.L., Willemze R., Zheng J., Cowan R., Foss F., Mangas C., Querfeld C., 2023/05. American journal of clinical dermatology, 24 (3) p. 493. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_09F55381218D]
 
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.
Quaglino P., Scarisbrick J., Roccuzzo G., Abeldano A., Battistella M., McCormack C., Cowan R., Cozzio A., Cury-Martins J., Enz P. et al., 2023/04. Journal of the European Academy of Dermatology and Venereology, 37 (4) pp. 680-688. Peer-reviewed.
[DOI][Pmid][serval:BIB_D7537C17C209]
International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.
Geskin L.J., Kwinta B.D., Garcia-Saleem T.J., Akilov O.E., Enz P.A., Guenova E., Ortiz-Romero P.L., Papadavid E., Quaglino P., Rozati S. et al., 2023/04. Journal of the American Academy of Dermatology, 88 (4) pp. 935-937. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4542D8A5917F]
Tinea capitis: actualité d’une pathologie ancienne [Tinea capitis: new insights into an old disease]
Blanchard M., Norrenberg S., Monod M., Morren M.A., Guenova E., 2023/03/29. Revue medicale suisse, 19 (820) pp. 618-623. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_23DFE7F57FEB]
Survey on Dermatophytes Isolated from Animals in Switzerland in the Context of the Prevention of Zoonotic Dermatophytosis.
Fratti M., Bontems O., Salamin K., Guenova E., Monod M., 2023/02/14. Journal of fungi, 9 (2) p. 253. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CA1DA1DAF463]
 
Clinical Reasoning: A 39-Year-Old Man With Asymmetric Distal Weakness and Loss of Sensitivity.
Loser V., Blanchard G., Guenova E., Théaudin M., Vicino A., 2023/01/10. Neurology, 100 (2) pp. 88-93. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_168DB9B36816]
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.
Hodak E., Geskin L., Guenova E., Ortiz-Romero P.L., Willemze R., Zheng J., Cowan R., Foss F., Mangas C., Querfeld C., 2023/01. American journal of clinical dermatology, 24 (1) pp. 5-14. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ACBF82B1C2A0]
2022
 
Precision medicine approach in a rare case of autosomal recessive congenital ichthyosis.
Ettinger M., Burner T., Lackner A., Schoeftner L.C., Holzgruber J., Gruber R., Guenova E., Schuetz-Bergmayr M., Fischer T., Gratz I.K. et al., 2022/12. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 20 (12) pp. 1651-1653. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_70112FBC718C]
 
Präzisionsmedizinischer Ansatz bei einem seltenen Fall von autosomal rezessiver kongenitaler Ichthyose.
Ettinger M., Burner T., Lackner A., Schoeftner L.C., Holzgruber J., Gruber R., Guenova E., Schuetz-Bergmayr M., Fischer T., Gratz I.K. et al., 2022/12. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 20 (12) pp. 1651-1654. Peer-reviewed.
[DOI][Pmid][serval:BIB_0413C3B8D04C]
 
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5.
Tusup M., Cheng P.F., Picardi E., Raziunaite A., Dummer R., Levesque M.P., French L.E., Guenova E., Kundig T.M., Pascolo S., 2022/11/21..
[DOI][WoS][Pmid][serval:BIB_E656531F7E16]
Granulomatous slack skin: clinical characteristics, prognosis and response to therapy. A study from the Cutaneous Lymphoma French Study Group.
Battesti G., Ram-Wolff C., Dobos G., Aubin F., Algros M.P., Guenova E., Joly P., Courville P., Mourah S., Cayuela J.M. et al., 2022/11. The British journal of dermatology, 187 (5) pp. 790-793. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_02DEF43FA5F1]
 
PTCH1 inactivation is sufficient to cause basaloid follicular hamartoma in paediatric Nevoid basal cell carcinoma syndrome.
Blanchard G., Yurchenko A.A., Pop O.T., Weibel L., Theiler M., Hauser V., Fraitag S., Guenova E., Flatz L., Nikolaev S.I. et al., 2022/11. Journal of the European Academy of Dermatology and Venereology, 36 (11) pp. e954-e956. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6DF7BA8D506C]
 
Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B., Cairoli A., Gaide O., Somja J., Bregnard C., Gaulard P., Xerri L., Lefort K., Missiaglia E., Gilliet M. et al., 2022/10. Virchows Archiv, 481 (4) pp. 653-657. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6CF9902CA42C]
 
Phaeohyphomycosis caused by Phialophora americana in a dog.
Martini F., Seehusen F., Krudewig C., Beckmann K.M., Favrot C., Fischer N.M., Guenova E., Rostaher A., 2022/10. Veterinary dermatology, 33 (5) pp. 446-449. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E5CF46384B0C]
Identification of Dermatophyte and Non-Dermatophyte Agents in Onychomycosis by PCR and DNA Sequencing-A Retrospective Comparison of Diagnostic Tools.
Pospischil I., Reinhardt C., Bontems O., Salamin K., Fratti M., Blanchard G., Chang Y.T., Wagner H., Hermann P., Monod M. et al., 2022/09/27. Journal of fungi, 8 (10) p. 1019. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DB3D0D62930E]
 
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.
Olsen E.A., Whittaker S., Willemze R., Pinter-Brown L., Foss F., Geskin L., Schwartz L., Horwitz S., Guitart J., Zic J. et al., 2022/08/04. Blood, 140 (5) pp. 419-437. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_727FFEC72880]
CD30+ Transformed Mycosis Fungoides Associated with Sweet-like Dermatosis
André Florine, Prins Christa, Gillet Michel, Guenova Emmanuella, Blanchard Gabriela, 2022/06/21. Acta Dermato-Venereologica, 102 pp. adv00739. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_903BF9F5F793]
Gene Amplification of CYP51B: a New Mechanism of Resistance to Azole Compounds in Trichophyton indotineae.
Yamada T., Yaguchi T., Maeda M., Alshahni M.M., Salamin K., Guenova E., Feuermann M., Monod M., 2022/06/21. Antimicrobial agents and chemotherapy, 66 (6) pp. e0005922. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_05785D0F47A2]
Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience.
Puxkandl V., Bangerl T., Hanfstingl K., Guenova E., Hoetzenecker W., Altrichter S., 2022/06. The World Allergy Organization journal, 15 (6) p. 100654. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FAFDEA56B0C2]
Chlormethin‐Gel zur Behandlung der Mycosis fungoides: Ein Expertenkonsens aus Deutschland, Österreich und der Schweiz (DACH‐Region) zum Therapiemanagement
Assaf Chalid, Booken Nina, Dippel Edgar, Guenova Emmanuella, Jonak Constanze, Klemke Claus-Detlev, Nicolay Jan P., Schlaak Max, Wobser Marion, Trautinger Franz, 2022/05. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 20 (5) pp. 579-588. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B17FFCEC8611]
 
Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T‐cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop.
Kempf W., Petrella T., Willemze R., Jansen P., Berti E., Santucci M., Geissinger E., Cerroni L., Maubec E., Battistella M. et al., 2022/05. The British journal of dermatology, 186 (5) pp. 887-897. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB2F05BF7238]
 
The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region).
Assaf C., Booken N., Dippel E., Guenova E., Jonak C., Klemke C.D., Nicolay J.P., Schlaak M., Wobser M., Trautinger F., 2022/05. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 20 (5) pp. 579-586. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9EDB11B33700]
Mycosis fongoïde et syndrome de Sézary : revue systématique [Mycosis fungoides and Sézary syndrome : a systematic review]
André F., Guenova E., Blanchard G., 2022/03/30. Revue medicale suisse, 18 (775) pp. 578-589. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C5B73CBE2CDF]
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.
Domizio J.D., Gulen M.F., Saidoune F., Thacker V.V., Yatim A., Sharma K., Nass T., Guenova E., Schaller M., Conrad C. et al., 2022/03. Nature, 603 (7899) pp. 145-151. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EB150385781D]
 
Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment.
Jomrich G., Kollmann D., Ramazanova D., Ristl R., Grose R.P., Ilhan-Mutlu A., Preusser M., Fassnacht C., Tsai Y.C., Guenova E. et al., 2022/02. European journal of surgical oncology, 48 (2) pp. 383-390. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7C80EE8E129C]
Acrokeratosis Paraneoplastica (Bazex Syndrome): A Case Report.
Holzgruber J., Oberneder-Popper J., Guenova E., Hötzenecker W., 2022. Case reports in dermatology, 14 (3) pp. 307-312. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_32CB9BCC02C5]
Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions.
Chang Y.T., Ignatova D., Hoetzenecker W., Pascolo S., Fassnacht C., Guenova E., 2022/01. JID innovations, 2 (1) p. 100069. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6E6C6BA75B7C]
 
Mogamulizumab-associated rash (MAR) mars its efficacy in the treatment of cutaneous lymphoma.
Blanchard G., Guenova E., 2022/01. The British journal of dermatology, 186 (1) pp. 15-16. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D238A090854]
 
Post hoc Analysis of a Randomized, Controlled, Phase 2 Study to Assess Response Rates with Chlormethine/Mechlorethamine Gel in Patients with Stage IA-IIA Mycosis Fungoides.
Querfeld C., Scarisbrick J.J., Assaf C., Guenova E., Bagot M., Ortiz-Romero P.L., Quaglino P., Bonizzoni E., Hodak E., 2022. Dermatology, 238 (2) pp. 347-357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F7F93EFFBD12]
 
Radiotherapy as a Treatment Option for Local Disease Control in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Zehnder M., Amarov B., Abrunhosa-Branquinho A.N., Maiwald-Urosevic M., Mühleisen B., Saulite I., Anzengruber F., Imhof L., Navarini A.A., Cozzio A. et al., 2022. Dermatology, 238 (5) pp. 967-976. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6A98B53A31C]
The A to I editing landscape in melanoma and its relation to clinical outcome.
Amweg A., Tusup M., Cheng P., Picardi E., Dummer R., Levesque M.P., French L.E., Guenova E., Läuchli S., Kundig T. et al., 2022/01. RNA biology, 19 (1) pp. 996-1006. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31BF88A84F09]
2021
 
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity.
Papadavid E., Kapniari E., Pappa V., Nikolaou V., Iliakis T., Dalamaga M., Jonak C., Porkert S., Engelina S., Quaglino P. et al., 2021/11. The British journal of dermatology, 185 (5) pp. 1035-1044. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_461B3C7D6937]
Mycosis fungoides-derived exosomes and their microRNA-1246 cargo: a message from the skin.
Pospischil I., Guenova E., 2021/11. The British journal of dermatology, 185 (5) pp. 884-886. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6D3543B48142]
 
A weakly supervised deep learning approach for label-free imaging flow-cytometry-based blood diagnostics.
Otesteanu C.F., Ugrinic M., Holzner G., Chang Y.T., Fassnacht C., Guenova E., Stavrakis S., deMello A., Claassen M., 2021/10/25. Cell reports methods, 1 (6) p. 100094. Peer-reviewed.
[DOI][Pmid][serval:BIB_A62E636357DA]
 
Granulomatous slack skin: clinical retrospective study of 8 cases of the Cutaneous Lymphoma French Study Group.
Battesti G., Ram-Wolff C., Dobos G., Aubin F., Algros M.P., Guenova E., Joly P., Courville P., Mourah S., Cayuela J.M. et al., 2021/10. European journal of cancer, 156 Suppl 1 pp. S35-S36. Peer-reviewed.
[DOI][Pmid][serval:BIB_EA033B0656AA]
 
Microvascular Skin Manifestations Caused by COVID-19.
Gawaz A., Guenova E., 2021/10. Hamostaseologie, 41 (5) pp. 387-396. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57DEEAE4BBB2]
Mycosis fungoides and Sézary syndrome.
Jonak C., Tittes J., Brunner P.M., Guenova E., 2021/09. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 19 (9) pp. 1307-1334. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4725444EC41C]
MFS1, a Pleiotropic Transporter in Dermatophytes That Plays a Key Role in Their Intrinsic Resistance to Chloramphenicol and Fluconazole.
Yamada T., Yaguchi T., Salamin K., Guenova E., Feuermann M., Monod M., 2021/07/07. Journal of fungi, 7 (7) p. 542. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B93AC25566CD]
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma
Tusup Marina, Läuchli Severin, Jarzebska Natalia Teresa, French Lars E., Chang Yun-Tsan, Vonow-Eisenring Maya, Su Andreas, Kündig Thomas M., Guenova Emmanuella, Pascolo Steve, 2021/07/07. Pharmaceutics, 13 (7) p. 1040. Peer-reviewed.
[URN][DOI][WoS][serval:BIB_7FA442B84D6D]
Cutaneous manifestations of SARS-CoV-2: A 2-center, prospective, case-controlled study.
Unterluggauer L., Pospischil I., Krall C., Saluzzo S., Kimeswenger S., Karolyi M., Wenisch C., Lamprecht B., Guenova E., Winkler S. et al., 2021/07. Journal of the American Academy of Dermatology, 85 (1) pp. 202-204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_13703C249918]
Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring.
Jarzebska N.T., Frei J., Lauchli S., French L.E., Guenova E., Gouttefangeas C., Kündig T.M., Mellett M., Pascolo S., 2021/06/25. Viruses, 13 (7) p. 1232. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BAAE03F7B1B0]
 
Artificial neural networks and pathologists recognize basal cell carcinomas based on different histological patterns.
Kimeswenger S., Tschandl P., Noack P., Hofmarcher M., Rumetshofer E., Kindermann H., Silye R., Hochreiter S., Kaltenbrunner M., Guenova E. et al., 2021/05. Modern pathology, 34 (5) pp. 895-903. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19315E9B8A3B]
 
Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study*
Quaglino P., Prince H.M., Cowan R., Vermeer M., Papadavid E., Bagot M., Servitjie O., Berti E., Guenova E., Stadler R. et al., 2021/04. British Journal of Dermatology, 184 (4) pp. 722-730. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A06208B6EDA0]
 
Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective.
Ramelyte E., Tastanova A., Balázs Z., Ignatova D., Turko P., Menzel U., Guenova E., Beisel C., Krauthammer M., Levesque M.P. et al., 2021/03/08. Cancer cell, 39 (3) pp. 394-406.e4. Peer-reviewed.
[DOI][Pmid][serval:BIB_B533AA4788A5]
 
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
Hodak E., Sherman S., Papadavid E., Bagot M., Querfeld C., Quaglino P., Prince H.M., Ortiz-Romero P.L., Stadler R., Knobler R. et al., 2021/03. The British journal of dermatology, 184 (3) pp. 524-531. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5DD67738ADEA]
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome.
Iselin C., Chang Y.T., Schlaepfer T., Fassnacht C., Dimitriou F., Nägeli M., Pascolo S., Hoetzenecker W., Bobrowicz M., Guenova E., 2021/01/31. Oncoimmunology, 10 (1) p. 1873530. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_008C6B39E645]
Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma.
Tusup M., Cheng P.F., Picardi E., Raziunaite A., Dummer R., Levesque M.P., French L.E., Guenova E., Kundig T.M., Pascolo S., 2021/01/12. Non-coding RNA, 7 (1) pp. E5. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_624A54C72BF4]
European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2.
Knobler R., Arenberger P., Arun A., Assaf C., Bagot M., Berlin G., Bohbot A., Calzavara-Pinton P., Child F., Cho A. et al., 2021/01. Journal of the European Academy of Dermatology and Venereology, 35 (1) pp. 27-49. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9775D6F86A74]
Programmed death ligand 2 expression plays a limited role in adenocarcinomas of the gastroesophageal junction after preoperative chemotherapy.
Jomrich G., Kollmann D., Wilfing L., Radosavljevic S., Ramazanova D., Ristl R., Grose R.P., Ilhan-Mutlu A., Preusser M., Fassnacht C. et al., 2021. European surgery, 53 (6) pp. 287-293. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB80F98C298F]
2020
European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1.
Knobler R., Arenberger P., Arun A., Assaf C., Bagot M., Berlin G., Bohbot A., Calzavara-Pinton P., Child F., Cho A. et al., 2020/12. Journal of the European Academy of Dermatology and Venereology, 34 (12) pp. 2693-2716. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C9DB07F9A968]
Functional differences between protamine preparations for the transfection of mRNA.
Jarzebska N.T., Lauchli S., Iselin C., French L.E., Johansen P., Guenova E., Kündig T.M., Pascolo S., 2020/12. Drug delivery, 27 (1) pp. 1231-1235. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79994ACC6FD3]
 
Hypersensitivity reactions to non-steroidal anti-inflammatory drugs: results of an Austrian cohort study
Bangerl Teresa, Zahel Brigitte, Lueger Andrea, Guenova Emmanuella, Angelova-Fischer Irena, Hoetzenecker Wolfram, 2020/11. Allergo Journal International, 29 (7) pp. 227-232. Peer-reviewed.
[DOI][WoS][serval:BIB_1141DBD9037E]
 
Pyoderma gangrenosum.
Maverakis E., Marzano A.V., Le S.T., Callen J.P., Brüggen M.C., Guenova E., Dissemond J., Shinkai K., Langan S.M., 2020/10/08. Nature reviews. Disease primers, 6 (1) p. 81. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E49FEE4ADF26]
 
Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study.
Brüggen M.C., Valencak J., Stranzenbach R., Li N., Stadler R., Jonak C., Bauer W., Porkert S., Blaschke A., Meiss F. et al., 2020/07. Journal of the European Academy of Dermatology and Venereology, 34 (7) pp. 1489-1495. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2680D836B84F]
Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors.
Bobrowicz M., Slusarczyk A., Domagala J., Dwojak M., Ignatova D., Chang Y.T., Iselin C., Miazek-Zapala N., Marhelava K., Guenova E. et al., 2020/07. Oncology letters, 20 (1) pp. 533-540. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_14EBB51169F2]
Epidemiology of Dermatophytoses in Switzerland According to a Survey of Dermatophytes Isolated in Lausanne between 2001 and 2018.
Bontems O., Fratti M., Salamin K., Guenova E., Monod M., 2020/06/26. Journal of fungi, 6 (2). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F288A251E38A]
A novel proangiogenic B cell subset is increased in cancer and chronic inflammation.
van de Veen W., Globinska A., Jansen K., Straumann A., Kubo T., Verschoor D., Wirz O.F., Castro-Giner F., Tan G., Rückert B. et al., 2020/05. Science advances, 6 (20) pp. eaaz3559. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_060EB45A34E7]
 
Sensitivity and specificity of T-cell receptor PCR BIOMED-2 clonality analysis for the diagnosis of cutaneous T-cell lymphoma.
Moczko A., Dimitriou F., Kresbach H., Amarov B., Hoetzenecker W., Pascolo S., Anzengruber F., Koch T., Duda A., Guenova E., 2020/02/01. European journal of dermatology, 30 (1) pp. 12-15. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F3945A7C649E]
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.
Saulite I., Ignatova D., Chang Y.T., Fassnacht C., Dimitriou F., Varypataki E., Anzengruber F., Nägeli M., Cozzio A., Dummer R. et al., 2020. Oncoimmunology, 9 (1) p. 1738797. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E73C64998C98]
 
Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
Pospischil I.M., Kagerer M., Cozzio A., Angelova-Fischer I., Guenova E., Ballmer-Weber B., Hoetzenecker W., 2020. International archives of allergy and immunology, 181 (10) pp. 783-789. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_42358D9FBCC8]
Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis.
Dimitriou F., Schanz U., Nair G., Kimeswenger S., Brüggen M.C., Hoetzenecker W., French L.E., Dummer R., Cozzio A., Guenova E., 2020. Frontiers in medicine, 7 p. 290. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D31A60BC3E59]
 
Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020.
Bobrowicz M., Fassnacht C., Ignatova D., Chang Y.T., Dimitriou F., Guenova E., 2020. International archives of allergy and immunology, 181 (10) pp. 733-745. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E41BEC470D91]
The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-Life Clinical Data
Amitay-Laish I, Guenova E, Ortiz-Romero P, Vico-Alonso C, Rozati S, Geskin L, Nikolaou V, Papadavid E, Barzilai A, Pavlovsky L et al., 2020. Acta Dermato Venereologica, 100 (16) pp. adv00277. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9DC16408D463]
2019
 
Efficacy and safety of colchicine in inflammatory skin diseases: a retrospective, monocentric study in a large tertiary center.
Anzengruber F, Graf V, Hafner J, Meienberer N, Guenova E, Dummer R, 2019/11. The Journal of dermatological treatment. Peer-reviewed.
[DOI][Pmid][serval:BIB_7D56543A4C70]
 
Ingenol mebutate for mycosis fungoides.
Ignatova D., Chang Y.T., Hoetzenecker W., Guenova E., 2019/11. The British journal of dermatology, 181 (5) pp. 1066-1068. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BF7C801BB1D3]
 
Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives.
Bobrowicz M., Zagozdzon R., Domagala J., Vasconcelos-Berg R., Guenova E., Winiarska M., 2019/09/24. Cancers, 11 (10). Peer-reviewed.
[DOI][Pmid][serval:BIB_6552A87633AA]
 
Dapsone in a Large Tertiary Center: Outdated Therapeutic Option or Timeless Agent?
Anzengruber F, Schenk J, Graf V, Nordmann TM, Guenova E, Dummer R, 2019/09. Dermatology (Basel, Switzerland). Peer-reviewed.
[DOI][Pmid][serval:BIB_EA05675C1F96]
 
Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant.
Bordignon P., Bottoni G., Xu X., Popescu A.S., Truan Z., Guenova E., Kofler L., Jafari P., Ostano P., Röcken M. et al., 2019/08/27. Cell reports, 28 (9) pp. 2358-2372.e6. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_450CF627543E]
 
Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update.
Ramelyte E, Dummer R, Guenova E, 2019/08. Expert opinion on investigational drugs. Peer-reviewed.
[DOI][Pmid][serval:BIB_CF09FE5332DD]
 
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
Scarisbrick J.J., Quaglino P., Prince H.M., Papadavid E., Hodak E., Bagot M., Servitje O., Berti E., Ortiz-Romero P., Stadler R. et al., 2019/08. The British journal of dermatology, 181 (2) pp. 350-357. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3E85CEC19B19]
 
Distribution of Human Papillomavirus Genotypes in Condylomata Acuminata: An Austrian Cohort Study.
Juelg E, Busch M, Lueger A, Guenova E, Schuetz-Bergmayr M, Hoetzenecker W, 2019/07. Dermatology (Basel, Switzerland). Peer-reviewed.
[DOI][Pmid][serval:BIB_AA1685710ED5]
 
Proteomic identification of a marker signature for MAPKi resistance in melanoma.
Paulitschke V, Eichhoff O, Gerner C, Paulitschke P, Bileck A, Mohr T, Cheng PF, Leitner A, Guenova E, Saulite I et al., 2019/06. The EMBO journal.
[DOI][Pmid][serval:BIB_9D7F9310C57C]
 
Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
Molloy K, Jonak C, Woei-A-Jin FJSH, Guenova E, Busschots AM, Bervoets A, Hauben E, Knobler R, Porkert S, Fassnacht C et al., 2019/05. The British journal of dermatology.
[DOI][Pmid][serval:BIB_93223352E662]
ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions.
Willrodt A.H., Salabarria A.C., Schineis P., Ignatova D., Hunter M.C., Vranova M., Golding-Ochsenbein A.M., Sigmund E., Romagna A., Strassberger V. et al., 2019. Frontiers in immunology, 10 p. 759. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_82DA802E7000]
 
Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome.
Anzengruber F, Ignatova D, Schlaepfer T, Chang YT, French LE, Pascolo S, Contassot E, Bobrowicz M, Hoetzenecker W, Guenova E, 2019/01. Leukemia & lymphoma.
[DOI][Pmid][serval:BIB_E46351D62A45]
Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn
Higgins R, Jensen A, Wachstein J, Bruckner-Tuderman L, Spiegel R, Traber H, Achermann J, Schaller M, Fehrenbacher B, Röcken M et al., 2019. Acta Dermato Venereologica p. 0.
[URN][DOI][Pmid][serval:BIB_C474A87F5298]
2018
 
Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement.
Doerschner M, Pekar-Lukacs A, Messerli-Odermatt O, Dommann-Scherrer C, Rütti M, Müller AM, Nair G, Kamarachev J, Kerl K, Beer M et al., 2018/12. The British journal of dermatology.
[DOI][Pmid][serval:BIB_8B8D6BE57E42]
 
Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations.
Luder CM, Nordmann TM, Ramelyte E, Mühleisen B, Kerl K, Guenova E, Dummer R, 2018/06. Journal of the European Academy of Dermatology and Venereology : JEADV. Peer-reviewed.
[DOI][Pmid][serval:BIB_23798E9DCEB6]
 
Individualized treatment approaches for Langerhans cell histiocytosis.
Roider E, Signer C, Fehrenbacher B, Metzler G, Schaller M, Kamarachev J, Kerl K, Balabanov S, Jochum W, Hoetzenecker W et al., 2018/06. The British journal of dermatology. Peer-reviewed.
[DOI][Pmid][serval:BIB_798D628F6F2D]
 
Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.
Stoffel E, Maier H, Riedl E, Brüggen MC, Reininger B, Schaschinger M, Bangert C, Guenova E, Stingl G, Brunner PM, 2018/05. The British journal of dermatology. Peer-reviewed.
[DOI][Pmid][serval:BIB_7CB76CF22004]
Pseudolymphomatous Reaction to Red Tattoo Pigment.
Saulite I, Pekar-Lukacs A, Kerl K, Cozzio A, Hoetzenecker W, Guenova E, 2018/05. Case reports in dermatology. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_455FED5ECFA6]
 
Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study.
Brüggen MC, Kerl K, Haralambieva E, Schanz U, Chang YT, Ignatova D, Dummer R, Cozzio A, Hoetzenecker W, French LE et al., 2018/04. Acta dermato-venereologica. Peer-reviewed.
[DOI][Pmid][serval:BIB_0CD13565274E]
 
Comparison of pyoderma gangrenosum and Martorell hypertensive ischaemic leg ulcer in a Swiss cohort.
Kolios AGA, Hafner J, Luder C, Guenova E, Kerl K, Kempf W, Nilsson J, French LE, Cozzio A, 2018/02. The British journal of dermatology. Peer-reviewed.
[DOI][Pmid][serval:BIB_F7C309CD678F]
 
Adverse Reactions of Antibody-Therapy for Primary Cutaneous Lymphomas: Rituximab, Brentuximab Vedotin, Alemtuzumab, and Mogamulizumab.
Saulite I., Guenova E., Hoetzenecker W., 2018. Current problems in dermatology, 53 pp. 70-81. Peer-reviewed.
[DOI][Pmid][serval:BIB_CF3AB1580107]
 
Dome-shaped Papules on the Left Flank: A Quiz. Cutaneous Rosai-Dorfman Disease (sinus histiocytosis with massive lymphadenopathy.
Roenneberg S, Hegyi I, Kempf W, Kerl K, Guenova E, 2018/01. Acta dermato-venereologica. Peer-reviewed.
[DOI][Pmid][serval:BIB_AF2C1C279138]
 
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma.
Kollmann D, Ignatova D, Jedamzik J, Chang YT, Jomrich G, Baierl A, Kazakov D, Michal M, French LE, Hoetzenecker W et al., 2018. Oncoimmunology. Peer-reviewed.
[DOI][Pmid][serval:BIB_B47999247C1B]
Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.
Hanfstingl K, Pekar-Lukacs A, Motz R, Guenova E, Hoetzenecker W, 2018. Case reports in dermatology. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7C37DD3FBE04]
2017
 
Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
Mangold AR, Thompson AK, Davis MD, Saulite I, Cozzio A, Guenova E, Hodak E, Amitay-Laish I, Pujol RM, Pittelkow MR et al., 2017/10. Journal of the American Academy of Dermatology. Peer-reviewed.
[DOI][Pmid][serval:BIB_382710AA22A0]
 
CME-Antworten.
Rebsamen U, Guenova E, Vallelian F, 2017/09. Praxis. Peer-reviewed.
[DOI][Pmid][serval:BIB_A7D090337374]
 
CME: Erythema nodosum.
Rebsamen U, Guenova E, Vallelian F, 2017/09. Praxis. Peer-reviewed.
[DOI][Pmid][serval:BIB_331B9229A925]
 
Expression of inflammatory cytokines in psoriatic nails.
Saulite I, Pilmane M, Guenova E, Kisis J, 2017/04. Journal of the European Academy of Dermatology and Venereology. Peer-reviewed.
[DOI][Pmid][serval:BIB_87A9F591A0C7]
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma.
Kollmann D, Ignatova D, Jedamzik J, Chang YT, Jomrich G, Paireder M, Kristo I, Kazakov D, Michal M, Cozzio A et al., 2017/04. Annals of Surgical Oncology. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B8E8380625F0]
Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome).
Mangana J, Guenova E, Kerl K, Urosevic-Maiwald M, Amann VC, Bayard C, Dummer R, French LE, 2017. Case reports in dermatology. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_79970D5F0CB8]
 
Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.
Kolios AGA, Gübeli A, Meier B, Maul JT, Kündig T, Nilsson J, Hafner J, Guenova E, Kerl K, Anliker M et al., 2017. Dermatology (Basel, Switzerland). Peer-reviewed.
[DOI][Pmid][serval:BIB_983F1B12FB1D]
 
PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer.
Kollmann D, Schweiger T, Schwarz S, Ignatova D, Chang YT, Lewik G, Schoppmann SF, Hoetzenecker W, Klepetko W, Guenova E et al., 2017. Oncoimmunology.
[DOI][Pmid][serval:BIB_A99CEF36F72C]
 
Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio.
Saulite I, Hoetzenecker W, Guenova E, Schmid-Grendelmeier P, Glatz M, 2017. International archives of allergy and immunology. Peer-reviewed.
[DOI][Pmid][serval:BIB_8E5EAC45B6AF]
TLR4 as a negative regulator of keratinocyte proliferation.
Iotzova-Weiss G, Freiberger SN, Johansen P, Kamarachev J, Guenova E, Dziunycz PJ, Roux GA, Neu J, Hofbauer GFL, 2017. PloS one. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_88791DF06107]
2016
 
An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.
Thurneysen S., Cheng P.F., Nagel H.W., Kunz M., Jaberg-Bentele N., Nägeli M., Ziegler M., Guenova E., Goldinger S.M., Mangana J. et al., 2016/11. The British journal of dermatology, 175 (5) pp. 966-978. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B287A12518AD]
 
Depth and Patterns of Adnexal Involvement in Primary Extramammary (Anogenital) Paget Disease: A Study of 178 Lesions From 146 Patients.
Konstantinova AM, Shelekhova KV, Stewart CJ, Spagnolo DV, Kutzner H, Kacerovska D, Plaza JA, Suster S, Bouda J, Pavlovsky M et al., 2016/11. The American Journal of Dermatopathology. Peer-reviewed.
[Pmid][serval:BIB_FD296497FED8]
 
Interleukin-1 receptor antagonist (anakinra) for Schnitzler syndrome.
Sönnichsen A, Saulite I, Mangana J, Kerl K, Mehra T, Desislava I, Chang YT, Petrausch U, Schmid-Grendelmeier P, Hoetzenecker W et al., 2016/10. Journal of Dermatological Treatment. Peer-reviewed.
[DOI][Pmid][serval:BIB_FD8A2FEBC43D]
 
Infundibulocystic Structures and Prominent Squamous Metaplasia in Sebaceoma-A Rare Feature. A Clinicopathologic Study of 10 Cases.
Flux K, Kutzner H, Rütten A, Plaza JA, Gasparov S, Michal M, Guenova E, Kazakov DV, 2016/09. The American Journal of Dermatopathology. Peer-reviewed.
[DOI][Pmid][serval:BIB_113D1F3C87F7]
 
Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations.
Konstantinova AM, Michal M, Kacerovska D, Spagnolo DV, Stewart CJ, Kutzner H, Zelger B, Plaza JA, Denisjuk N, Hejda V et al., 2016/08. The American Journal of Dermatopathology. Peer-reviewed.
[DOI][Pmid][serval:BIB_DCF6CB6E94EF]
 
Toxic epidermal necrolysis
Hoetzenecker Wolfram, Mehra Tarun, Saulite Ieva, Glatz Martin, Schmid-Grendelmeier Peter, Guenova Emmanuella, Cozzio Antonio, French Lars E., 2016/05/20. F1000Research, 5 p. 951. Peer-reviewed.
[DOI][Pmid][serval:BIB_E2E6C08D6FDA]
 
Expression of CD164 on Malignant T cells in Sézary Syndrome.
Guenova E., Ignatova D., Chang Y.T., Contassot E., Mehra T., Saulite I., Navarini A.A., Mitev V., Dummer R., Kazakov D.V. et al., 2016/05. Acta dermato-venereologica, 96 (4) pp. 464-467. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_097B800A362F]
 
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study.
Kunz M., Urosevic-Maiwald M., Goldinger S.M., Frauchiger A.L., Dreier J., Belloni B., Mangana J., Jenni D., Dippel M., Cozzio A. et al., 2016/02. Journal of the European Academy of Dermatology and Venereology, 30 (2) pp. 293-298. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3EFB14016A2D]
 
Adverse cutaneous drug eruptions: current understanding.
Hoetzenecker W., Nägeli M., Mehra E.T., Jensen A.N., Saulite I., Schmid-Grendelmeier P., Guenova E., Cozzio A., French L.E., 2016/01. Seminars in immunopathology, 38 (1) pp. 75-86. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8642388B4B42]
Cutaneous Oncology: From Research to Diagnosis and Management
Saulite Ieva, Roider Elisabeth, Darlenksi Razvigor, Jalili Ahmad, Guenova Emmanuella, 2016. BioMed Research International, 2016 pp. 1-2. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_327F969F56A7]
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets.
Saulite I., Hoetzenecker W., Weidinger S., Cozzio A., Guenova E., Wehkamp U., 2016. BioMed research international, 2016 p. 9717530. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_966C0C4FCBD9]
2015
 
Diagnostic relevance of direct immunofluorescence in ocular mucous membrane pemphigoid.
Mehra T., Guenova E., Dechent F., Würth F., Zierhut M., Röcken M., Schaller M., Deuter C., 2015/12. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology, 13 (12) pp. 1268-1274. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A795723CCF5A]
 
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth.
Kleffel S., Posch C., Barthel S.R., Mueller H., Schlapbach C., Guenova E., Elco C.P., Lee N., Juneja V.R., Zhan Q. et al., 2015/09/10. Cell, 162 (6) pp. 1242-1256. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EFA7514C3942]
 
Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine.
Amann V.C., Dreier J., Ignatova D., Kamarashev J., Kerl K., Kempf W., Pascolo S., Dummer R., Cozzio A., Guenova E., 2015/05. Acta dermato-venereologica, 95 (5) pp. 602-603. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9B1D366D9D2B]
 
Recent advances in primary cutaneous T-cell lymphoma.
DeSimone J.A., Sodha P., Ignatova D., Dummer R., Cozzio A., Guenova E., 2015/03. Current opinion in oncology, 27 (2) pp. 128-133. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_32A19CB07408]
 
IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells.
Guenova E., Skabytska Y., Hoetzenecker W., Weindl G., Sauer K., Tham M., Kim K.W., Park J.H., Seo J.H., Ignatova D. et al., 2015/02/17. Proceedings of the National Academy of Sciences of the United States of America, 112 (7) pp. 2163-2168. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2C343E244C18]
 
Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.
Mehra T., Ikenberg K., Moos R.M., Benz R., Nair G., Schanz U., Haralambieva E., Hoetzenecker W., Dummer R., French L.E. et al., 2015/01. JAMA dermatology, 151 (1) pp. 73-77. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5614D00FB1E2]
 
Inpatient Treatment for Severe Nonsurgical Dermatological Disorders: Prevalence, Care Infrastructure and Reimbursement in Switzerland.
Mehra T., Hoetzenecker W., Moos R., Volbracht J., Guenova E., French L.E., Hafner J., 2015. Dermatology, 231 (3) pp. 260-268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_93DA4B6ABDD9]
 
The Phytotherapeutic Fenugreek as Trigger of Toxic Epidermal Necrolysis.
Bentele-Jaberg N., Guenova E., Mehra T., Nägeli M., Chang Y.T., Cozzio A., French L.E., Hoetzenecker W., 2015. Dermatology, 231 (2) pp. 99-102. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7BE78050599D]
2014
 
Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells.
Skabytska Y., Wölbing F., Günther C., Köberle M., Kaesler S., Chen K.M., Guenova E., Demircioglu D., Kempf W.E., Volz T. et al., 2014/11/20. Immunity, 41 (5) pp. 762-775. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_514AA3E34FFE]
 
Parental anxiety and concern for children undergoing dermatological surgery.
Hoetzenecker W., Guenova E., Krug M., Goetz A., Amarov B., Haefner H.M., Breuninger H., 2014/10. The Journal of dermatological treatment, 25 (5) pp. 367-370. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C87869AEEA7B]
 
Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma.
Guenova E., Schanz S., Hoetzenecker W., DeSimone J.A., Mehra T., Voykov B., Urosevic-Maiwald M., Berneburg M., Dummer R., French L.E. et al., 2014/10. The British journal of dermatology, 171 (4) pp. 891-894. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_41732CDCD148]
 
Carbonic anhydrase IX is associated with early pulmonary spreading of primary colorectal carcinoma and tobacco smoking.
Schweiger T., Kollmann D., Nikolowsky C., Traxler D., Guenova E., Lang G., Birner P., Klepetko W., Ankersmit H.J., Hoetzenecker K., 2014/07. European journal of cardio-thoracic surgery, 46 (1) pp. 92-99. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F313782CE763]
 
Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S., Volz T., Skabytska Y., Köberle M., Hein U., Chen K.M., Guenova E., Wölbing F., Röcken M., Biedermann T., 2014/07. The Journal of allergy and clinical immunology, 134 (1) pp. 92-99. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C7A188B527AB]
 
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
Guenova E., Hoetzenecker W., Rozati S., Levesque M.P., Dummer R., Cozzio A., 2014/04. Expert opinion on investigational drugs, 23 (4) pp. 457-467. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FBE93840ED1D]
 
Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs' uveitis syndrome?
Voykov B., Deuter C., Zierhut M., Leitritz M.A., Guenova E., Doycheva D., 2014/03. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 252 (3) pp. 485-489. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CC82A0D235CC]
 
Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.
Schlapbach C., Gehad A., Yang C., Watanabe R., Guenova E., Teague J.E., Campbell L., Yawalkar N., Kupper T.S., Clark R.A., 2014/01/15. Science translational medicine, 6 (219) pp. 219ra8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45B0DC2B96F2]
 
Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells.
Volz T., Skabytska Y., Guenova E., Chen K.M., Frick J.S., Kirschning C.J., Kaesler S., Röcken M., Biedermann T., 2014/01. The Journal of investigative dermatology, 134 (1) pp. 96-104. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_680F0ABC043B]
Primary localization and tumor thickness as prognostic factors of survival in patients with mucosal melanoma.
Mehra T., Grözinger G., Mann S., Guenova E., Moos R., Röcken M., Claussen C.D., Dummer R., Clasen S., Naumann A. et al., 2014. PloS one, 9 (11) pp. e112535. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7DFCAAE42EAE]
2013
 
Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.
Berneburg M., Herzinger T., Rampf J., Hoetzenecker W., Guenova E., Meisner C., Maetzke J., Schaefer T., Eberlein B., Scharffetter-Kochanek K. et al., 2013/09. The British journal of dermatology, 169 (3) pp. 704-708. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6818B67DF1BE]
 
Less can be more: the impact of chemotherapy on cutaneous T-cell lymphomas.
Dummer R., Rozati S., Guenova E., Cozzio A., 2013/08. Future oncology, 9 (8) pp. 1061-1064. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_42A4A45108D1]
 
TH2 Cytokines from Malignant Cells Suppress TH1 Responses and Enforce a Global TH2 Bias in Leukemic Cutaneous T-cell Lymphoma
Guenova E., Watanabe R., Teague J. E., Desimone J. A., Jiang Y., Dowlatshahi M., Schlapbach C., Schaekel K., Rook A. H., Tawa M. et al., 2013/07/15. Clinical Cancer Research, 19 (14) pp. 3755-3763.
[DOI][WoS][Pmid][serval:BIB_5AEFB74F3FF2]
 
Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma.
DeSimone J.A., Guenova E., Carter J.B., Chaney K.S., Aldridge J.R., Noell C.M., Dorosario A.A., Hansen J.L., Kupper T.S., Devlin P.M., 2013/07. Journal of the American Academy of Dermatology, 69 (1) pp. 61-65. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BAA724EC522D]
 
High levels of lung resident CD4+CD28null cells in COPD: implications of autoimmunity.
Hoetzenecker K., Mitterbauer A., Guenova E., Schweiger T., Altmann P., Zimmermann M., Hofbauer H., Beer L., Klepetko W., Ankersmit H.J., 2013/03. Wiener klinische Wochenschrift, 125 (5-6) pp. 150-155. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3BCD19B8372A]
 
Banana leaves as an alternative wound dressing.
Guenova E., Hoetzenecker W., Kisuze G., Teske A., Heeg P., Voykov B., Hoetzenecker K., Schippert W., Moehrle M., 2013/02. Dermatologic surgery, 39 (2) pp. 290-297. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_89788BDC7033]
Incidental Finding of Lamellar Calcification of the Falx Cerebri Leading to the Diagnosis of Gorlin-Goltz Syndrome
Saulite I., Voykov B., Mehra T., Hoetzenecker W., Guenova E., 2013. Case Reports in Dermatology, 5 (3) pp. 301-303. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_41CB6090ECBF]
 
Treatment of pyoderma gangrenosum with topical factor XIII.
Hoetzenecker W., Guenova E., Mitev V., Schanz S., Ulmer A., Fierlbeck G., 2013. European journal of dermatology, 23 (5) pp. 653-657. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8ADA453251EB]
2012
 
Residents' corner November 2012. CarpeDIEM – Dermatological Indications for Electron Microscopy: Disseminated epidermolytic acanthomas
Guenova Emmanuella, Eberle Franziska C., Metzler Gisela, Schaller Martin, 2012/11. European Journal of Dermatology, 22 (6) pp. 822-823. Peer-reviewed.
[DOI][WoS][serval:BIB_9A708B1E4A9D]
 
Residents' corner September 2012. CarpeDIEM – Dermatological Indications for Electron Microscopy: Argyria
Guenova Emmanuella, Schaller Martin, 2012/09. European Journal of Dermatology, 22 (5) pp. 718-718. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_734CEBCD80A4]
 
Residents' corner July 2012. CarpeDIEM – Dermatological Indications for Electron Microscopy: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Guenova Emmanuella, Schaller Martin, 2012/07. European Journal of Dermatology, 22 (4) pp. 586-587. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0629421765A0]
 
Residents'corner July 2012. Residents' editorial choice
Torres Tiago, Guenova Emmanuella, Feldmeyer Laurence, Nosbaum Audrey, 2012/07. European Journal of Dermatology, 22 (4) pp. 584-585. Peer-reviewed.
[DOI][WoS][serval:BIB_79A4EF6E8ED5]
 
Residents' corner May 2012. CarpeDIEM – Dermatological Indications for Electron Microscopy: Herpesvirus infection
Guenova Emmanuella, Schaller Martin, 2012/05. European Journal of Dermatology, 22 (3) pp. 440-440. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_789530871FB2]
 
Residents' corner May 2012. Residents' editorial choice
Nosbaum Audrey, Feldmeyer Laurence, Torres Tiago, Guenova Emmanuella, 2012/05. European Journal of Dermatology, 22 (3) pp. 438-438. Peer-reviewed.
[DOI][WoS][serval:BIB_3D8F6E00B89D]
 
Ustekinumab for Pyoderma Gangrenosum—Reply
Guenova Emmanuella, Walker Florian, Teske Anna, Fehrenbacher Birgit, Hoerber Sebastian, Adamczyk Annette, Schaller Martin, Hoetzenecker Wolfram, Biedermann Tilo, 2012/05/01. Archives of Dermatology, 148 (5). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F0835DF55C79]
 
Case 1-2012: a man with persistent ulcers on the hands.
Guenova E., Hoetzenecker W., 2012/04/12. The New England journal of medicine, 366 (15) pp. 1450; author reply 1450. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_60AF23CCB907]
 
CarpeDIEM – Dermatological Indications for Electron Microscopy: Orf infection
Guenova Emmanuella, Schaller Martin, 2012/03. European Journal of Dermatology, 22 (2) pp. 293-293. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EAEFDFD3056E]
 
(Carpe)DIEM - dermatological indications for electron microscopy: Amyloid deposition. [corrected].
Guenova E., Schaller M., 2012. European journal of dermatology, 22 (1) p. 161. Peer-reviewed.
[DOI][Pmid][serval:BIB_624B13B44B0F]
 
Interstitial granulomatous dermatitis with arthritis responding to tocilizumab.
Schanz S., Schmalzing M., Guenova E., Metzler G., Ulmer A., Kötter I., Fierlbeck G., 2012/01. Archives of dermatology, 148 (1) pp. 17-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50EAA9BA58BE]
 
Residents' corner January 2012. CarpeDIEM – Dermatological Indications for Electron Microscopy : Ehlers Danlos Syndrome
Guenova Emmanuella, Schaller Martin, 2012/01. European Journal of Dermatology, 22 (1) pp. 161-161. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0A04CAE8B24]
2011
 
ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression.
Hoetzenecker W., Echtenacher B., Guenova E., Hoetzenecker K., Woelbing F., Brück J., Teske A., Valtcheva N., Fuchs K., Kneilling M. et al., 2011/12/18. Nature medicine, 18 (1) pp. 128-134. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A7FEDC1F1E50]
 
Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab.
Guenova E., Teske A., Fehrenbacher B., Hoerber S., Adamczyk A., Schaller M., Hoetzenecker W., Biedermann T., 2011/10. Archives of dermatology, 147 (10) pp. 1203-1205. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7D2E0AB92C30]
 
Residents'corner July 2011.
Feldmeyer L., Guenova E., Torres T., Nosbaum A., 2011/08. European journal of dermatology, 31 (4) pp. 651-653. Peer-reviewed.
[DOI][Pmid][serval:BIB_A814E7C7FD20]
 
Residents'corner May 2011
Feldmeyer Laurence, Guenova Emmanuella, Torres Tiago, Nosbaum Audrey, 2011/05. European Journal of Dermatology, 21 (3) pp. 462-463. Peer-reviewed.
[DOI][WoS][serval:BIB_2A52CE837AC2]
 
Treatment of recurrent aphthous stomatitis with fumaric acid esters.
Guenova E., Hoetzenecker W., 2011/03. Archives of dermatology, 147 (3) pp. 282-284. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B50CCD210D32]
 
Mapping of specific sentinel node locations for skin cancer of the head.
Hoetzenecker W., Guenova E., Böttinger T.U., Häfner H.M., Breuninger H., 2011. European journal of dermatology, 21 (3) pp. 354-358. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A744E1CCCB47]
 
Residents' corner March 2011.
Feldmeyer L., Guenova E., Torres T., Nosbaum A., 2011. European journal of dermatology, 21 (2) pp. 304-306. Peer-reviewed.
[DOI][Pmid][serval:BIB_65B66D32F426]
 
Residents' corner November 2011. Residents' editorial choice.
Torres T., Guenova E., Feldmeyer L., Nosbaum A., 2011. European journal of dermatology, 21 (6) p. 1029. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57701BFFF011]
 
Residents' corner September 2011. (Carpe)DIEM - Birbeck granule in Langerhans cell histiocytosis.
Guenova E., Schaller M., 2011. European journal of dermatology, 21 (5) p. 827. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74C24F3EA017]
 
Residents' corner September 2011. Residents' editorial choice.
Feldmeyer L., Guenova E., Torres T., Nosbaum A., 2011. European journal of dermatology, 21 (5) pp. 826-827. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A9687A755E3]
 
Residents'corner May 2011.
Feldmeyer L., Guenova E., Torres T., Nosbaum A., 2011. European journal of dermatology, 21 (3) pp. 461-462. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_254CE61BFBBD]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University